The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis.

Connie M. Rhee | L. Kiemeney | G. Hankey | J. Sgarbi | D. Bauer | N. Rodondi | R. Westendorp | M. Vanderpump | J. Jukema | M. Kavousi | T. Ittermann | M. Dörr | S. Trompet | R. Peeters | H. Fink | B. Yeap | L. Chaker | M. Medici | A. Cappola | J. Gussekloo | K. Boelaert | R. Dullaart | G. Ceresini | S. Razvi | G. Iervasi | M. Imaizumi | N. Wareham | Bert Vaes | L. Wildisen | T. Korevaar | Fereidoun Azizi | A. Derakhshan | Ola Hysaj | S. Brown | I. Benseñor | Marcus Dörr | Bu B Yeap | Henry Völzke | Nick Wareham | Fereidoun Azizi | Massimo Iacoviello | Jacobijn Gussekloo | Heinz Drexel | M. Ikram | Luigi Ferrucci | Yanning Xu | Arash Derakhshan | Ola Hysaj | Lea Wildisen | Till Ittermann | Alessandro Pingitore | Nazanin Abolhassani | Marco Medici | Lambertus A L M Kiemeney | Niels P Riksen | Robin P F Dullaart | Stella Trompet | Suzanne J Brown | Börge Schmidt | Dagmar Führer-Sakel | Mark P J Vanderpump | Axel Muendlein | Howard A Fink | M Kamran Ikram | Maryam Kavousi | Connie M Rhee | Isabela M Bensenor | Graeme J Hankey | Misa Imaizumi | Graziano Ceresini | José A Sgarbi | Douglas C Bauer | Kristien Boelaert | Stephan J L Bakker | J Wouter Jukema | Bert Vaes | Giorgio Iervasi | Rudi G J Westendorp | Tim I M Korevaar | Salman Razvi | John P Walsh | Anne R Cappola | Nicolas Rodondi | Robin P Peeters | Layal Chaker | H. Völzke | Luigi Ferrucci | Stephan J. L. Bakker | J. Walsh | Yanning Xu | Alessandro Pingitore | Nazanin Abolhassani | Niels P Riksen | Börge Schmidt | Dagmar Führer-Sakel | A. Muendlein | Heinz Drexel | Howard A Fink | Massimo Iacoviello | J. Walsh | M. Iacoviello | L. Ferrucci | H. Drexel | Dagmar Führer-Sakel | N. Riksen

[1]  Hua Peng,et al.  Hyperlipidemia and hypothyroidism. , 2022, Clinica chimica acta; international journal of clinical chemistry.

[2]  J. Ross,et al.  Levothyroxine Use in the United States, 2008-2018. , 2021, JAMA internal medicine.

[3]  C. Bulpitt,et al.  SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. , 2021, European heart journal.

[4]  A. Barkun,et al.  Relative risk rather than absolute risk reduction should be preferred to sensitise the public to preventive actions , 2021, Gut.

[5]  R. Gans,et al.  Thyroid function and risk of all-cause and cardiovascular mortality: a prospective population-based cohort study , 2020, Endocrine.

[6]  N. Bean,et al.  Clinical Parameters Are More Likely to Be Associated with Thyroid Hormone Levels than with Thyrotropin Levels: A Systematic Review and Meta-Analysis , 2020, Thyroid : official journal of the American Thyroid Association.

[7]  Connie M. Rhee,et al.  Association of Subclinical Hypothyroidism and Cardiovascular Disease With Mortality. , 2020, JAMA network open.

[8]  Catrin Tudur Smith,et al.  Individual participant data meta‐analysis of intervention studies with time‐to‐event outcomes: A review of the methodology and an applied example , 2019, Research synthesis methods.

[9]  L. Stewart,et al.  Retrieval of individual patient data depended on study characteristics: A randomised controlled trial. , 2019, Journal of clinical epidemiology.

[10]  Daniel E Forman,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[11]  N. Rodondi,et al.  Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline , 2019, BMJ.

[12]  T. Streichert,et al.  Distinguishing reference intervals and clinical decision limits – A review by the IFCC Committee on Reference Intervals and Decision Limits , 2018, Critical reviews in clinical laboratory sciences.

[13]  O. Franco,et al.  Thyroid Function and the Risk of Atherosclerotic Cardiovascular Morbidity and Mortality: The Rotterdam Study , 2017, Circulation research.

[14]  P. Macfarlane,et al.  Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation , 2017, Circulation.

[15]  F. Azizi,et al.  Thyroid Dysfunction States and Incident Cardiovascular Events: The Tehran Thyroid Study , 2017, Hormone and Metabolic Research.

[16]  A. Uitterlinden,et al.  Thyroid Function Tests in the Reference Range and Fracture: Individual Participant Analysis of Prospective Cohorts , 2017, The Journal of clinical endocrinology and metabolism.

[17]  O. Franco,et al.  Defining Optimal Health Range for Thyroid Function Based on the Risk of Cardiovascular Disease , 2017, The Journal of clinical endocrinology and metabolism.

[18]  Vincent Audigier,et al.  Multiple Imputation for Multilevel Data with Continuous and Binary Variables , 2017, 1702.00971.

[19]  T. Tsujimoto,et al.  Association Between Serum Thyrotropin Levels and Mortality Among Euthyroid Adults in the United States. , 2016 .

[20]  O. Franco,et al.  Thyroid Function and Cancer Risk: The Rotterdam Study. , 2016, The Journal of clinical endocrinology and metabolism.

[21]  O. Franco,et al.  Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis. , 2016, The Journal of clinical endocrinology and metabolism.

[22]  O. Franco,et al.  Thyroid Function and Sudden Cardiac DeathClinical Perspective , 2016 .

[23]  O. Franco,et al.  Thyroid Function Characteristics and Determinants: The Rotterdam Study. , 2016, Thyroid : official journal of the American Thyroid Association.

[24]  O. Franco,et al.  Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study. , 2016, The Journal of clinical endocrinology and metabolism.

[25]  S. Bandinelli,et al.  Relationship Between Circulating Thyroid‐Stimulating Hormone, Free Thyroxine, and Free Triiodothyronine Concentrations and 9‐Year Mortality in Euthyroid Elderly Adults , 2016, Journal of the American Geriatrics Society.

[26]  Karel G M Moons,et al.  Imputation of systematically missing predictors in an individual participant data meta‐analysis: a generalized approach using MICE , 2015, Statistics in medicine.

[27]  B. Psaty,et al.  Thyroid function in the euthyroid range and adverse outcomes in older adults. , 2015, The Journal of clinical endocrinology and metabolism.

[28]  L. Kiemeney,et al.  Associations between thyroid function and mortality: the influence of age. , 2014, European journal of endocrinology.

[29]  A. D. de Craen,et al.  Thyroid status and renal function in older persons in the general population. , 2014, The Journal of clinical endocrinology and metabolism.

[30]  G. Brabant,et al.  2013 ETA Guideline: Management of Subclinical Hypothyroidism , 2013, European Thyroid Journal.

[31]  G. Hankey,et al.  Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health In Men Study. , 2013, European journal of endocrinology.

[32]  E. Lim,et al.  The relationship between TSH and free T₄ in a large population is complex and nonlinear and differs by age and sex. , 2013, The Journal of clinical endocrinology and metabolism.

[33]  Irwin Klein,et al.  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. , 2012, Thyroid : official journal of the American Thyroid Association.

[34]  E. Vittinghoff,et al.  Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: An Individual Participant Data Analysis From 6 Prospective Cohorts , 2012, Circulation.

[35]  J. Franklyn,et al.  Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. , 2012, Archives of internal medicine.

[36]  B. Duncan,et al.  Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. , 2012, American journal of epidemiology.

[37]  P. Macfarlane,et al.  Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. , 2012, The Journal of clinical endocrinology and metabolism.

[38]  J. Franklyn,et al.  Subclinical hypothyroidism and the risk of coronary heart disease and mortality. , 2010, JAMA.

[39]  A. Pasquet,et al.  The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium , 2010, BMC geriatrics.

[40]  M. Vanderpump,et al.  The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. , 2010, The Journal of clinical endocrinology and metabolism.

[41]  J. Sgarbi,et al.  Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study. , 2010, European journal of endocrinology.

[42]  S. Sauer,et al.  Decreased serum TSH levels are not associated with mortality in the adult northeast German population. , 2010, European journal of endocrinology.

[43]  R. Luben,et al.  Initial thyroid status and cardiovascular risk factors: The EPIC‐Norfolk prospective population study , 2010, Clinical endocrinology.

[44]  R. Riley,et al.  Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.

[45]  C. Forleo,et al.  Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients. , 2008, Current pharmaceutical design.

[46]  J. Jonklaas,et al.  Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. , 2008, JAMA.

[47]  A. L'Abbate,et al.  Association between increased mortality and mild thyroid dysfunction in cardiac patients. , 2007, Archives of internal medicine.

[48]  L. Fried,et al.  Thyroid status, cardiovascular risk, and mortality in older adults. , 2006, JAMA.

[49]  Peter O'Leary,et al.  Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. , 2005, Archives of internal medicine.

[50]  S. Cummings,et al.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. , 2005, Contemporary clinical trials.

[51]  A. Hida,et al.  Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. , 2004, The Journal of clinical endocrinology and metabolism.

[52]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[53]  D. Grönemeyer,et al.  Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. , 2002, American heart journal.

[54]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[55]  J. Franklyn,et al.  Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study , 2001, The Lancet.

[56]  R. Jackson.  Guidelines on preventing cardiovascular disease in clinical practice , 2000, BMJ : British Medical Journal.

[57]  G A Colditz,et al.  Guidelines for healthy weight. , 1999, The New England journal of medicine.

[58]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[59]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[60]  R. Peeters.  Subclinical Hypothyroidism , 2017, The New England journal of medicine.

[61]  A. Zaman,et al.  Thyroid hormones and cardiovascular disease , 2017, Nature Reviews Cardiology.

[62]  K. Geiger,et al.  High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis. , 2016, Atherosclerosis.

[63]  A. Sayers,et al.  Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. , 2014, JAMA internal medicine.

[64]  E. Simonsick,et al.  Thyroid function and prevalent and incident metabolic syndrome in older adults: the health, ageing and body composition study , 2012, Clinical endocrinology.

[65]  Edward G Lakatta,et al.  Aging-associated cardiovascular changes and their relationship to heart failure. , 2012, Heart failure clinics.

[66]  Miguel A Hernán,et al.  The hazards of hazard ratios. , 2010, Epidemiology.

[67]  H. L. Bleich,et al.  Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. , 1982, The New England journal of medicine.